TAB3 O-GlcNAcylation promotes metastasis of triple negative breast cancer
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SUPPLEMENTARY MATERIALS AND METHODS
Reagents and antibodies
GlcNAcstatin was obtained from GlycoBioChem. Human IL-1β was from Protech. Click-iT™ O-GlcNAc Enzymatic Labeling System and Click-iT™ Biotin Protein Analysis Detection Kit were obtained from Invitrogen. GlycoProfile β-elimination kit was obtained from Sigma. The antibodies used in this study include: rabbit monoclonal antiFlag antibody, rabbit polyclonal anti-HA antibody (Sigma), rabbit polyclonal anti-GAPDH antibodies (Santa Cruz), rabbit monoclonal anti-TAB3 antibody, rabbit monoclonal anti-TAK1/phosphorylated-TAK1 antibodies, rabbit monoclonal anti-NF-κBp65/phosphorylated-NF-κBp65 antibodies, rabbit monoclonal anti-p38/phosphorylated-p38 antibodies mouse monoclonal anti-O-GlcNAcylation CTD110.6 antibody (Cell Signaling Technology). The rabbit polyclonal anti-Thr404 phosphorylated-TAB3 antibodies and rabbit polyclonal anti-Ser408 O-GlcNAcylated-TAB3 antibody were made according to the classic approach.
Cell proliferation assay
Cell proliferation was measured using the MTT assay. Briefly, cells were seeded onto 96-well cell culture cluster plates at a concentration of 10 4 cells/well in volumes of 100 μL, and grown overnight. MTT Reagents were added to the subset of wells, and then incubated for 2 hours at 37°C, the DMSO was added to detergent. Absorbances were quantified using an automated plate reader at 370 nm. 
Supplementary
Supplementary Figure S4: IL-1β promotes TAB3 O-GlcNAcylation and TAK1 activation in TNBC cells. (A)
The specificity of the antibody which against TAB3 O-GlcNAc S408 was determined using cell lysates prepared from cells transfected with WT TAB3 and S408A TAB3 treated with or without 1 mM GlcNAcstatin. (B) MAD-MB-231 cells were serum starved for 6 h, and then stimulated by IL-1β for 15 min. Cell lysate were immunoblotted for O-GlcNAcylated-TAB3 (gSer408 TAB3), phosphorylated TAK1and total TAB3 and TAK1. Densitometries for TAB3 OGlcNAcylation and TAK1 phosphorylation were normalized against total TAB3 and TAK1 levels. (C) The TAK1 complexes were pulled down from the cell extracts (1 mg of protein extract) using glutathione-sepharose beads, and TAK1 activity assays were performed as described in the materials and methods section. Kaplan-Meier survival curve of breast cancer patients with low and high total O-GlcNAcylation level. 
Supplementary Table S1: Primers used in the manuscript
